Relapsed/Refractory Hematologic Autoimmune Disease research hub

Safety and Preliminary Efficacy of CTX112 in Adult Participants with Relapsed/Refractory Hematologic Autoimmune Disease

This study is looking at a new treatment called CTX112 for adults with certain blood (hematologic) autoimmune diseases that haven't responded to usual treatments. It's the first time this treatment is being tested in people, focusing on its safety and how well it might work.